Ravgen, Inc. v. Laboratory Corporation of America Holdings

  1. May 15, 2023

    Ravgen's Prenatal Test Patent Win Boosted To $372M

    U.S. District Judge Alan Albright has agreed to enhance biotechnology company Ravgen's $272 million jury award in its patent suit against rival Labcorp over a testing method for genetic disorders, adding $100 million to the jury verdict partly because the infringement occurred "for a long time."

  2. December 22, 2022

    The Top Patent Damages Awards Of 2022

    Patent owners won relatively modest damages awards in their infringement battles in 2022, marking a departure from the massive verdicts and judgments handed down by juries and judges over the previous two years.

  3. December 08, 2022

    IP Forecast: Del. Judge To Keep Probing Patent Biz Ownership

    Delaware's top judge is set to hold another hearing next week in an investment company's fight against his controversial disclosure requirements, which could torpedo one of the firm's billion-dollar lawsuits against Intel. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.

  4. October 20, 2022

    LabCorp Tells Albright Not To Triple $272M IP Judgment

    LabCorp has urged U.S. District Judge Alan Albright not to enhance a $272 million jury verdict against it in a biotechnology company's patent suit over a testing method for genetic disorders, saying the jurors' willful infringement finding doesn't warrant tripling the damages.

  5. October 05, 2022

    Biotech Asks Albright To Triple LabCorp IP Damages To $817M

    A small biotech business that won a $272 million verdict last month against LabCorp on Wednesday asked U.S. District Court Judge Alan Albright to triple the damages the jury awarded over its finding that LabCorp willfully infringed a patent covering a genetic disorder testing method, saying it deserves $817 million instead.

  6. September 23, 2022

    Jury Says LabCorp Owes $272M For Infringing Prenatal Test IP

    A federal jury in Waco, Texas, found on Friday afternoon that LabCorp, one of the largest chains of clinical lab providers in the world, owes more than $272 million to a small Maryland biotech business for willfully infringing a patent covering a method of testing for genetic disorders during pregnancy.

  7. September 19, 2022

    LabCorp Infringed Prenatal Test IP, Biotech Biz Tells Jury

    In a Waco, Texas, courtroom on Monday, a small Maryland biotech business claimed its founder revolutionized prenatal testing over 20 years ago, and LabCorp, one of the largest chains of clinical lab providers in the world, owes his company "a couple hundred million dollars" for infringing his patents.

  8. September 15, 2022

    IP Forecast: PTAB To Eye Patent Tied To Intel's $2.2B Loss

    The Patent Trial and Appeal Board next week will dive into a controversial legal effort to wipe out claims in a microchip patent tied to part of a $2.18 billion jury verdict against Intel that's being closely watched by the tech industry, lawmakers and the patent office's director. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.